Xiaofan Li
Sutro Biopharma (United States)(US)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research, Click Chemistry and Applications, CAR-T cell therapy research, Radiopharmaceutical Chemistry and Applications
Most-Cited Works
- → Production of Site-Specific Antibody–Drug Conjugates Using Optimized Non-Natural Amino Acids in a Cell-Free Expression System(2014)352 cited
- → Targeting CD74 in multiple myeloma with the novel, site-specific antibody-drug conjugate STRO-001(2018)52 cited
- → Exploration of the carmaphycins as payloads in antibody drug conjugate anticancer agents(2018)43 cited
- → High frequency of CD74 expression in lymphomas: implications for targeted therapy using a novel anti‐CD74‐drug conjugate(2018)43 cited
- → RF1 attenuation enables efficient non-natural amino acid incorporation for production of homogeneous antibody drug conjugates(2017)38 cited
- → A novel cyclic dipeptide from deep marine-derived fungus Aspergillus sp. SCSIOW2(2015)31 cited
- → RP-HPLC DAR Characterization of Site-Specific Antibody Drug Conjugates Produced in a Cell-Free Expression System(2016)30 cited
- → Electron donor–acceptor complex-catalyzed photoredox reactions mediated by DIPEA and inorganic carbonates(2022)26 cited
- → Toward a Ferrous Iron-Cleavable Linker for Antibody–Drug Conjugates(2018)18 cited
- → Development of an E. coli strain for cell‐free ADC manufacturing(2021)16 cited